Literature DB >> 27344374

The long intergenic non-coding RNA CCR492 functions as a let-7 competitive endogenous RNA to regulate c-Myc expression.

Mara Maldotti1, Danny Incarnato1, Francesco Neri2, Anna Krepelova1, Stefania Rapelli2, Francesca Anselmi1, Caterina Parlato2, Giulia Basile1, Daniela Dettori3, Raffaele Calogero3, Salvatore Oliviero4.   

Abstract

In mammals the cell-cycle progression through the G1 phase is a tightly regulated process mediated by the transcriptional activation of early genes in response to mitogenic stimuli, whose dysregulation often leads to tumorigenesis. We here report the discovery by RNA-seq of cell-cycle regulated (CCR) long intergenic non-coding RNAs (lincRNAs), potentially involved in the control of the cell-cycle progression. We identified 10 novel lincRNAs expressed in response to serum treatment in mouse embryonic fibroblasts (MEFs) and in BALB/c fibroblasts, comparably to early genes. By loss-of-function experiments we found that lincRNA CCR492 is required for G1/S progression, localizes in the cell cytoplasm and contains 4 let-7 microRNA recognition elements (MREs). Mechanistically, CCR492 functions as a competing endogenous RNA (ceRNA) to antagonize the function of let-7 microRNAs, leading to the de-repression of c-Myc. Moreover, we show that ectopic expression of CCR492 along with a constitutively active H-Ras promotes cell transformation. Thus, we identified a new lincRNA expressed as an early gene in mammalian cells to regulate the cell-cycle progression by upregulating c-Myc expression.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cell cycle; Let-7; Non-coding RNA; c-Myc; ceRNA

Mesh:

Substances:

Year:  2016        PMID: 27344374     DOI: 10.1016/j.bbagrm.2016.06.010

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

Review 1.  The role of lncRNA-mediated ceRNA regulatory networks in pancreatic cancer.

Authors:  Jichuan Xu; Jian Xu; Xinyuan Liu; Jianxin Jiang
Journal:  Cell Death Discov       Date:  2022-06-14

2.  RNAs competing for microRNAs mutually influence their fluctuations in a highly non-linear microRNA-dependent manner in single cells.

Authors:  Carla Bosia; Francesco Sgrò; Laura Conti; Carlo Baldassi; Davide Brusa; Federica Cavallo; Ferdinando Di Cunto; Emilia Turco; Andrea Pagnani; Riccardo Zecchina
Journal:  Genome Biol       Date:  2017-02-20       Impact factor: 13.583

Review 3.  Let-7 as biomarker, prognostic indicator, and therapy for precision medicine in cancer.

Authors:  Evgeny Chirshev; Kerby C Oberg; Yevgeniya J Ioffe; Juli J Unternaehrer
Journal:  Clin Transl Med       Date:  2019-08-28

4.  Long noncoding RNA GSTM3TV2 upregulates LAT2 and OLR1 by competitively sponging let-7 to promote gemcitabine resistance in pancreatic cancer.

Authors:  Guangbing Xiong; Chang Liu; Gang Yang; Mengyu Feng; Jianwei Xu; Fangyu Zhao; Lei You; Li Zhou; Lianfang Zheng; Ya Hu; Xiaowo Wang; Taiping Zhang; Yupei Zhao
Journal:  J Hematol Oncol       Date:  2019-09-12       Impact factor: 17.388

5.  The lncRNA FEZF1-AS1 Promotes the Progression of Colorectal Cancer Through Regulating OTX1 and Targeting miR-30a-5p.

Authors:  Jing Li; Lian-Mei Zhao; Cong Zhang; Meng Li; Bo Gao; Xu-Hua Hu; Jian Cao; Gui-Ying Wang
Journal:  Oncol Res       Date:  2019-07-03       Impact factor: 5.574

6.  NBPF4 mitigates progression in colorectal cancer through the regulation of EZH2-associated ETFA.

Authors:  Wankun Chen; Zhou Di; Zhaoyuan Chen; Ke Nan; Jiahui Gu; Feng Ge; Jinlong Liu; Hao Zhang; Changhong Miao
Journal:  J Cell Mol Med       Date:  2021-08-18       Impact factor: 5.310

7.  LncRNA BIRF Promotes Brain Ischemic Tolerance Induced By Cerebral Ischemic Preconditioning Through Upregulating GLT-1 via Sponging miR-330-5p.

Authors:  Shichao Li; Lingyan Zhang; Jiajie Lin; Achou Su; Xiyun Liu; Jingge Zhang; Xiaohui Xian; Yuyan Hu; Wenbin Li; Shaoguang Sun; Min Zhang
Journal:  Mol Neurobiol       Date:  2022-04-22       Impact factor: 5.682

Review 8.  Intricate crosstalk between MYC and non-coding RNAs regulates hallmarks of cancer.

Authors:  Lotteke J Y M Swier; Agnieszka Dzikiewicz-Krawczyk; Melanie Winkle; Anke van den Berg; Joost Kluiver
Journal:  Mol Oncol       Date:  2018-12-05       Impact factor: 6.603

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.